SNDL
SNDL, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$1.43
+5.56%Next report
Analyst consensus
- Next report date
- Mar 18, 2027
- EPS estimate
- -$0.03
- Revenue estimate
- $173.7M
Latest reported
- Last report date
- Oct 27, 2026
- EPS actual
- -$0.15
- EPS estimate
- -$0.01
- Revenue actual
- $167.1M
- Revenue estimate
- $164.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -312.8%
- Revenue beats (12Q)
- 3
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 27, 2026 | -$0.01 | -$0.15 | Miss -949.68% | $167.1M |
| Jul 28, 2026 | -$0.00 | -$0.02 | Miss -468.18% | $166.0M |
| Apr 29, 2026 | -$0.03 | -$0.03 | In line | $140.8M |
| Mar 12, 2026 | $0.01 | $0.03 | Beat 166.76% | $183.9M |
| Jul 31, 2025 | -$0.04 | $0.01 | Beat 125.00% | $179.7M |
| May 1, 2025 | -$0.06 | -$0.04 | Beat 33.33% | $143.9M |
| Mar 18, 2025 | -$0.01 | -$0.19 | Miss -1800.00% | $179.1M |
| Aug 1, 2024 | -$0.04 | -$0.01 | Beat 75.00% | $166.9M |
| Mar 20, 2024 | -$0.12 | -$0.22 | Miss -83.33% | $187.1M |
| Nov 13, 2023 | $0.01 | -$0.06 | Miss -915.22% | $175.4M |
| Aug 14, 2023 | $0.01 | -$0.08 | Miss -1161.01% | $184.6M |
| May 15, 2023 | $0.01 | -$0.07 | Miss -1047.23% | $149.6M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 18, 2027